Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
12.45
-0.16 (-1.27%)
At close: Apr 17, 2026, 4:00 PM EDT
12.47
+0.02 (0.16%)
After-hours: Apr 17, 2026, 6:04 PM EDT
Generate Biomedicines Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$23.20
Upside
+86.35%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +28.51% | Apr 13, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +108.84% | Mar 24, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $20 | Buy | Initiates | $20 | +60.64% | Mar 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $24 | Buy | Initiates | $24 | +92.77% | Mar 24, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 24, 2026 |
| Guggenheim | Guggenheim | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +140.96% | Mar 24, 2026 |